230 related articles for article (PubMed ID: 22864739)
1. Inclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppository.
Balakrishnan P; Song CK; Cho HJ; Yang SG; Kim DD; Yong CS; Choi HG
Arch Pharm Res; 2012 Jul; 35(7):1169-75. PubMed ID: 22864739
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anti-tumor activity and alleviated hepatotoxicity of clotrimazole-loaded suppository using poloxamer-propylene glycol gel.
Yong CS; Xuan JJ; Paek SH; Oh YK; Woo JS; Lee MH; Kim JA; Choi HG
Int J Pharm; 2006 Sep; 321(1-2):56-61. PubMed ID: 16790328
[TBL] [Abstract][Full Text] [Related]
3. Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin.
Prabagar B; Yoo BK; Woo JS; Kim JA; Rhee JD; Piao MG; Choi HG; Yong CS
Arch Pharm Res; 2007 Feb; 30(2):249-54. PubMed ID: 17366748
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole:beta-cyclodextrin complex.
Bilensoy E; Rouf MA; Vural I; Sen M; Hincal AA
AAPS PharmSciTech; 2006 Apr; 7(2):E38. PubMed ID: 16796356
[TBL] [Abstract][Full Text] [Related]
6. The effect of beta-cyclodextrin complexation on the bioavailability and hepatotoxicity of clotrimazole.
Yong CS; Li DX; Prabagar B; Park BC; Yi SJ; Yoo BK; Lyoo WS; Woo JS; Rhee JD; Kim JA; Choi HG
Pharmazie; 2007 Oct; 62(10):756-9. PubMed ID: 18236780
[TBL] [Abstract][Full Text] [Related]
7. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
[TBL] [Abstract][Full Text] [Related]
8. Baicalein and hydroxypropyl-γ-cyclodextrin complex in poloxamer thermal sensitive hydrogel for vaginal administration.
Zhou Q; Zhong L; Wei X; Dou W; Chou G; Wang Z
Int J Pharm; 2013 Sep; 454(1):125-34. PubMed ID: 23850236
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
11. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
Jug M; Kosalec I; Maestrelli F; Mura P
J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
[TBL] [Abstract][Full Text] [Related]
12. Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol.
Yong CS; Oh YK; Jung SH; Rhee JD; Kim HD; Kim CK; Choi HG
Eur J Pharm Sci; 2004 Dec; 23(4-5):347-53. PubMed ID: 15567287
[TBL] [Abstract][Full Text] [Related]
13. Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes.
Balata G; Mahdi M; Bakera RA
Indian J Pharm Sci; 2011 Sep; 73(5):517-26. PubMed ID: 22923864
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin.
Dhanaraju MD; Kumaran KS; Baskaran T; Moorthy MS
Drug Dev Ind Pharm; 1998 Jun; 24(6):583-7. PubMed ID: 9876628
[TBL] [Abstract][Full Text] [Related]
15. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
16. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
17. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
[TBL] [Abstract][Full Text] [Related]
18. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
19. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
20. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
